newsfilter
← Latest News
Business Wire·

PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays

Streamlined workflows aim to shorten research and development for novel therapies to combat diseases like cancer and Alzheimer's PerkinElmer, Inc., (NYSE:PKI), a global leader committed to innovating for a